Close Menu
Technology Mag

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    AT&T says ‘our network’ wasn’t to blame for Trump’s troubled conference call

    June 30, 2025

    The government’s Apple antitrust lawsuit is still on

    June 30, 2025

    Apple’s AI Siri might be powered by OpenAI

    June 30, 2025
    Facebook X (Twitter) Instagram
    Subscribe
    Technology Mag
    Facebook X (Twitter) Instagram YouTube
    • Home
    • News
    • Business
    • Games
    • Gear
    • Reviews
    • Science
    • Security
    • Trending
    • Press Release
    Technology Mag
    Home » Philips stops selling sleep apnea machines in US following mass recalls
    News

    Philips stops selling sleep apnea machines in US following mass recalls

    News RoomBy News RoomJanuary 31, 20242 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Philips is halting sales of its recalled sleep apnea machines in the US after finding they were pumping foam particles into users’ airways. In its earnings report on Monday, the company says it will not sell new CPAP or BiPAP devices in the US until it meets the requirements outlined by the Food and Drug Administration.

    Philips first issued a recall on its sleep apnea machines in 2021 over “potential health risks.” The recall includes devices made between 2009 and April 21st, 2021, and stems from a polyester-based polyurethane foam Philips included in the machines to minimize sound and vibration. As noted by Philips, that foam “can break down,” leading the person using the device to breathe it in or swallow it, resulting in potential injury.

    The company says it has reached a consent decree with the Department of Justice and FDA. It doesn’t go into detail about the terms of the agreement because it is still pending approval by a court. However, we do know that Philips will still provide service to sleep and respiratory devices in the US and will also continue to sell the machines outside of the US. Philips, which is headquartered in the Netherlands, has set aside €363 million (about $394 million) to address the FDA’s requirements.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticleCrypto mines will have to start reporting their energy use in the US
    Next Article These Are Our Favorite Sheets to Catch Some Z’s

    Related Posts

    AT&T says ‘our network’ wasn’t to blame for Trump’s troubled conference call

    June 30, 2025

    The government’s Apple antitrust lawsuit is still on

    June 30, 2025

    Apple’s AI Siri might be powered by OpenAI

    June 30, 2025

    The Nintendo Switch 2 will be available in-store at Best Buy on July 1st

    June 30, 2025

    Mark Zuckerberg announces his AI ‘superintelligence’ super-group

    June 30, 2025

    Jackery’s outdoor charging gear is cheaper than ever

    June 30, 2025
    Our Picks

    The government’s Apple antitrust lawsuit is still on

    June 30, 2025

    Apple’s AI Siri might be powered by OpenAI

    June 30, 2025

    The best Switch 2 screen protector you should buy

    June 30, 2025

    The Nintendo Switch 2 will be available in-store at Best Buy on July 1st

    June 30, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Security

    Telegram Purged Chinese Crypto Scam Markets—Then Watched as They Rebuilt

    By News RoomJune 30, 2025

    Before they were taken down by Telegram, Xinbi Guarantee and Haowang Guarantee displayed similar posts…

    Mark Zuckerberg announces his AI ‘superintelligence’ super-group

    June 30, 2025

    OpenAI Loses 4 Key Researchers to Meta

    June 30, 2025

    Jackery’s outdoor charging gear is cheaper than ever

    June 30, 2025
    Facebook X (Twitter) Instagram Pinterest
    • Privacy Policy
    • Terms of use
    • Advertise
    • Contact
    © 2025 Technology Mag. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.